When a major automaker stumbles, competitors often see their biggest opportunity in years to win over customers and capture meaningful market share.
Toyota's recall could accelerate the shift to electric vehicles as consumers explore alternatives, benefiting EV leaders like Tesla and emerging Chinese manufacturers.
Auto parts suppliers serving Toyota's rivals may see increased orders as these companies ramp up production to meet new demand from displaced customers.
Toyota's recall of over 126,000 vehicles due to engine defects creates a rare opportunity for competitors to gain market share. When a trusted brand faces quality issues, consumers often look elsewhere, creating openings for rival automakers and their supply chains to capture new business.
This group includes traditional automakers like GM and Ford, electric vehicle leaders like Tesla, and the parts suppliers that support them. The automotive industry is cyclical, meaning these companies can see significant swings based on consumer confidence and market disruptions like recalls.
Each company was handpicked by professional analysts based on their ability to benefit from Toyota's recall situation. From direct competitors who can attract displaced customers to parts suppliers who may see increased orders as rivals ramp up production to meet new demand.
Toyota has recalled over 126,000 vehicles due to an engine stall risk, creating a potential loss of consumer confidence. This situation presents an opportunity for competing automakers and their parts suppliers to capture market share from a key rival.
This basket's total market capitalisation is 1,885,641.136 and is heavily anchored by a very large-cap constituent, creating pronounced large-cap concentration.
TSLA: $1.43T
GM: $67.02B
F: $53.59B
+8
Here are a few of the assets in this group. Create an account to unlock the full list.
General Motors
GM
Aktueller Kurs
$82.03
As a primary competitor to Toyota, General Motors is well-positioned to attract customers who may be hesitant to purchase a Toyota following the recal...
As a primary competitor to Toyota, General Motors is well-positioned to attract customers who may be hesitant to purchase a Toyota following the recall.
Join Nemo FREE today and unlock every stock
Es dauert nur 60 Sekunden.
Analysten erwarten im Durchschnitt, dass die Werte dieser Gruppe im nächsten Jahr um 160.19 % zulegen.
14 von 18 Werten dieser Gruppe werden von professionellen Analysten mit „Kaufen“ bewertet.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
Wenn Sie in diese Werte investieren:
In 12 Monaten könnte der Wert betragen:
+160.19%
Erfahren Sie alles über diesen Aktienkorb. Lesen Sie unseren ausführlichen Artikel zu seinen Risiken und seinem Potenzial.
Vollständige Analyse lesen
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
